Sol-Gel Technologies Profit Margin 2016-2024 | SLGL
Current and historical gross margin, operating margin and net profit margin for Sol-Gel Technologies (SLGL) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Sol-Gel Technologies net profit margin as of September 30, 2024 is -81.75%.
| Sol-Gel Technologies Annual Profit Margins |
| Sol-Gel Technologies Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.013B |
$0.002B |
|
Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.
|
